| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/12/2007 | US20070160660 solid dietary and/or nutraceutic pharmaceutical compositions for oral use based on S-adenosylmethionine, or salts thereof, in combination with inositol and/or derivatives thereof with the addition of magnesium oxide as stabilizer |
| 07/12/2007 | US20070160659 Stabilized formulations of phosphatidylserine |
| 07/12/2007 | US20070160657 Targeting and intestinal-absorption controlled liposome having sugar chain and therapeutic drug for cancer and diagnostic drug containing the liposome |
| 07/12/2007 | US20070160656 Lipid platinum complexes and methods of use thereof |
| 07/12/2007 | US20070160655 Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases |
| 07/12/2007 | US20070160650 Stimulating nitric oxide production and white blood cell production for antiviral activity; oral administration of neurotransmitter precursors, along with natural plant extracts that stimulate uptake of the neurotransmitters precursors, and other plant substances for side effect reduction |
| 07/12/2007 | US20070160647 Materials for medical implants and occlusive devices |
| 07/12/2007 | US20070160642 Implantable medical devices coated with a polymer-bound superoxide dismutase mimic |
| 07/12/2007 | US20070160641 Coated medical devices and methods of making the same |
| 07/12/2007 | US20070160639 Drug delivery systems using mesoporous oxide films |
| 07/12/2007 | US20070160632 Polyinosinic acid-polycytidylic acid-based adjuvant |
| 07/12/2007 | US20070160625 Prepared by extracting fungi Marasmius androsaceus L.es Fr with an organic solvent, an aqueous organic solvent or water, and concentrating the obtained extractive; use in treatment of cardiovascular disorders |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | US20070160608 Treatment with anti-vegf antibodies |
| 07/12/2007 | US20070160592 Method for treatment of macular degeneration |
| 07/12/2007 | US20070160591 Peri-operative and peri-procedure nutritional supplementation |
| 07/12/2007 | US20070160590 Metabolic uncoupling therapy |
| 07/12/2007 | US20070160569 Medical adhesive and methods of tissue adhesion |
| 07/12/2007 | US20070160568 Polyamino acids functionalized by at least one hydrophobic group and the therapeutic application thereof |
| 07/12/2007 | US20070160567 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/12/2007 | US20070160566 Anti-microbial and oxidative co-polymer |
| 07/12/2007 | US20070160562 Delivery devices for hair-promoting cosmetic agent |
| 07/12/2007 | US20070160559 Skin disinfectant composition and methods for using |
| 07/12/2007 | US20070160554 Acyl ribonucleosides and acyl deoxyribonucleosides, compositions of, and methods of making same |
| 07/12/2007 | US20070160553 Use of agents for the cosmetic treatment of keratin-containing material |
| 07/12/2007 | US20070160547 Method of applying a composition |
| 07/12/2007 | US20070160545 Method for reducing ultraviolet light induced apoptosis |
| 07/12/2007 | US20070160542 Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 07/12/2007 | US20070160541 Bronchodilating beta-agonist compositions and methods |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/12/2007 | US20070160527 Use of n-acetyl-d-aminoglycosamine in treatment of local lesions or systematic symptoms related to autoimmune reactions |
| 07/12/2007 | US20070158227 Plaster enclosing packaging bag |
| 07/12/2007 | DE60125335T2 Azacyclische verbindungen zur verwendung in der behandlung von mit serotonin verwandten krankheiten Azacyclic compounds for use in the treatment of serotonin-related diseases |
| 07/12/2007 | DE202007004942U1 Kosmetische oder dermatologische Zubereitung Cosmetic or dermatological preparation |
| 07/12/2007 | DE102006002427A1 Neue Lysolipin Derivate New Lysolipin derivatives |
| 07/12/2007 | DE102006001213A1 Synergistische Lösung aus Ascobinsäure oder deren Derivaten und Metallionen effizienten, selektiven Abtötung pathologischer Säugerzellen Synergistic solution of Ascobinsäure or their derivatives and metal ions efficient, selective killing of pathological mammalian cells |
| 07/12/2007 | DE102005056527A1 Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels Use of a combination of ethinyl estradiol and chlormadinone acetate in the manufacture of a medicament |
| 07/12/2007 | DE102005055957A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 07/12/2007 | DE102005054610A1 Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung Flupirtine-containing pharmaceutical composition with controlled drug release |
| 07/12/2007 | DE10161251B4 Schlafmittel mit Xenon Sleeping pills with xenon |
| 07/12/2007 | DE10045904B4 alpha-Liponsäure(-Derivate) enthaltende Retardform alpha-lipoic acid (derivatives) containing sustained release form |
| 07/12/2007 | CA2847871A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 07/12/2007 | CA2671322A1 Compositions and methods for treating actin-mediated medical conditions by administering an actin modulating agent |
| 07/12/2007 | CA2641421A1 Small molecule inhibitors of pdz interactions |
| 07/12/2007 | CA2640889A1 Pharmaceutical composition for the treatment of nail diseases |
| 07/12/2007 | CA2636929A1 Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
| 07/12/2007 | CA2636278A1 A dietary fibre comprising water-soluble .beta.-glucan and use thereof for treating or preventing metabolic syndrome |
| 07/12/2007 | CA2636264A1 Bicyclic heteroaryl compounds as pde10 inhibitors |
| 07/12/2007 | CA2635994A1 Drug delivery system for bioadhesion to a vulvovaginal surface |
| 07/12/2007 | CA2635992A1 Medicament for topical use |
| 07/12/2007 | CA2635986A1 Composition and method of use thereof |
| 07/12/2007 | CA2635850A1 Heterocyclic janus kinase 3 inhibitors |
| 07/12/2007 | CA2635845A1 Prokineticin 2 receptor antagonists |
| 07/12/2007 | CA2635842A1 Prokineticin 1 receptor antagonists |
| 07/12/2007 | CA2635840A1 Process for manufacturing picolinate borinic esters |
| 07/12/2007 | CA2635802A1 Imidazo (1,2-a)pyridin-3-yl-acetic acid hydrazides, processes for their preparation and pharmaceutical uses thereof |
| 07/12/2007 | CA2635801A1 Cleansing composition |
| 07/12/2007 | CA2635680A1 Boron-containing small molecules |
| 07/12/2007 | CA2635649A1 New pharmaceutical compositions based on anticholinergics and andolast |
| 07/12/2007 | CA2635610A1 Extracts of chenopodium ambrosioides l., the compositions comprising said extracts, the preparing process and application thereof |
| 07/12/2007 | CA2635581A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 07/12/2007 | CA2635580A1 Substituted bis-amide metalloprotease inhibitors |
| 07/12/2007 | CA2635541A1 Fused heterocyclic compounds and their use as mineralocorticoid receptor ligands |
| 07/12/2007 | CA2635468A1 Methods for improving the pharmacokinetics of hiv integrase inhibitors |
| 07/12/2007 | CA2635466A1 Gastric retentive gabapentin dosage forms and methods for using same |
| 07/12/2007 | CA2635463A1 Novel phytic citrate compounds and process for preparing the same |
| 07/12/2007 | CA2635396A1 Carbonates of fenicol antibiotics |
| 07/12/2007 | CA2635335A1 Muscarinic receptor antagonists |
| 07/12/2007 | CA2635318A1 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases |
| 07/12/2007 | CA2635261A1 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/12/2007 | CA2635252A1 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 07/12/2007 | CA2635231A1 Protein kinase inhibitors |
| 07/12/2007 | CA2634993A1 Concentrated liquid thyroid hormone composition |
| 07/12/2007 | CA2634984A1 Use of tiotropium salts in the treatment of moderate persistent asthma |
| 07/12/2007 | CA2634983A1 Macrocyclic compounds useful as bace inhibitors |
| 07/12/2007 | CA2634896A1 Na+, k+-atpase expression in cervical dysplasia and cancer |
| 07/12/2007 | CA2634743A1 Modified lysine-mimetic compounds |
| 07/12/2007 | CA2634670A1 Method of identifying compounds useful to treat neuronal degenerative diseases |
| 07/12/2007 | CA2634334A1 Interfering rnas targeting the morbillivirus nucleoprotein gene |
| 07/12/2007 | CA2634320A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 07/12/2007 | CA2634120A1 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/12/2007 | CA2634074A1 Asymmetric reduction method |
| 07/12/2007 | CA2634037A1 2-amino-5-piperidinylimidazolone compounds and use thereof for .beta.-secretase modulation |
| 07/12/2007 | CA2633804A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis |
| 07/12/2007 | CA2633624A1 3,5-substituted piperidine compounds as renin inhibitors |
| 07/12/2007 | CA2633402A1 Preparation of pharmaceutical salts of 3-o-(3',3'-dimethlsuccinyl) betulinic acid |
| 07/12/2007 | CA2633285A1 Method for isolating (r)-tofisopam |
| 07/12/2007 | CA2633259A1 Practical, cost-effective synthesis of ubiquinones |
| 07/12/2007 | CA2633167A1 Pharmaceutical compositions of combinations of dipeptidyl peptidase-4 inhibitors with metformin |
| 07/12/2007 | CA2633013A1 A method of treatment |
| 07/12/2007 | CA2632854A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 07/12/2007 | CA2631108A1 Combination comprising combretastatin and anticancer agents |
| 07/12/2007 | CA2630613A1 Cancer stem cells and uses thereof |
| 07/12/2007 | CA2630235A1 Lansoprazole orally disintegrating tablets |
| 07/12/2007 | CA2629148A1 Pdf inhibitors |
| 07/12/2007 | CA2627684A1 Metaxalone formulations and methods for the preparation thereof |
| 07/12/2007 | CA2571156A1 Electrolyte supplement and method of use |
| 07/11/2007 | WO2008096188A2 Spray dispensers |
| 07/11/2007 | EP1806585A1 Detection, monitoring and treatment of cancer |